Global Smart Inhalers Market 2022-2028

Global Smart Inhalers Market 2022-2028

Inhalers are used to treat chronic obstructive pulmonary disease (COPD), such as asthma, by delivering bronchodilator medication to the airway directly, without passing through the blood. A smart inhaler is an inhaler that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use. The global smart inhalers market size is projected to grow by USD 536 million from 2022 to 2028, registering a CAGR of 21.7 percent, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart inhalers market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart inhalers industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, disorder, and region. The global market for smart inhalers can be segmented by product: dry powder inhaler (DPI)-based smart inhalers , metered-dose inhaler (MDI)-based smart inhalers. Among these, the MDI-based smart inhalers segment was accounted for the highest revenue generator in 2021. Smart inhalers market is further segmented by disorder: asthma, chronic obstructive pulmonary disease (COPD). The asthma segment is estimated to account for the largest share of the global smart inhalers market. Based on region, the smart inhalers market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). Europe held the largest share of the global smart inhalers market in 2021 and is anticipated to hold its share during the forecast period.

By product:

• dry powder inhaler (DPI)-based smart inhalers
• metered-dose inhaler (MDI)-based smart inhalers

By disorder:

• asthma
• chronic obstructive pulmonary disease (COPD)

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report has also analysed the competitive landscape of the global smart inhalers market with some of the key players being AstraZeneca plc, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc (GSK), Heitkamp & Thumann KG, Novartis International AG, OPKO Health, Inc. (OPK), Teva Pharmaceutical Industries Ltd., Vectura Group plc, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global smart inhalers market.
• To classify and forecast the global smart inhalers market based on product, disorder, region.
• To identify drivers and challenges for the global smart inhalers market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global smart inhalers market.
• To identify and analyze the profile of leading players operating in the global smart inhalers market.

Why Choose This Report

• Gain a reliable outlook of the global smart inhalers market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.